Latest Headlines
-
New Technique Can Quickly Detect Fentanyl And Other Opioids
2/22/2024
University of Waterloo researchers have developed a new blood testing method that can detect potent opioids much faster than traditional approaches and potentially save lives.
-
CTI Announces Additional College Of American Pathologists (CAP) Laboratory Accreditation
2/21/2024
CTI Clinical Trials and Consulting, a full-service global research provider, is thrilled to announce that our North American laboratory facility has been granted the prestigious College of American Pathologists (CAP) Accreditation for Safety Testing.
-
Mainz Biomed Establishes Strategic Partnership With TomaLab To Expand Availability Of ColoAlert® in Italy
2/21/2024
Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a leader in molecular genetics diagnostic solutions for early cancer detection, announced today a strategic partnership with TomaLab to launch the Company’s flagship product, ColoAlert® in Italy. TomaLab is one of Italy’s premier biotechnology laboratories and is based in Milan.
-
AION Labs, In Continued Partnership With BioMed X, Launches First 2024 Global Call For Applications: AI/ML Platform For Targeting RNA With Small Molecules
2/20/2024
AION Labs, the first-of-its-kind venture studio spearheading the adoption of AI technologies and computational science to solve therapeutic challenges, and German independent research institute BioMed X, announced today the launch of its latest global call for applications to identify computational biologists, biomedical scientists and inventors to form a new startup at AION Labs' headquarters in Rehovot, Israel.
-
Wright State University Foundation, altafiber, Nokia Open 5G Test Lab At Emergence Center One
2/20/2024
The Wright State University Foundation, altafiber, and Nokia are pleased to announce the opening of a 5G Test Lab at Emergence Center One located at 3070 Presidential Drive in Fairborn, Ohio.
-
New MEDITECH Expanse Pathology Solution Streamlines Pathologist Workflows
2/20/2024
MEDITECH announces the release of its redesigned Expanse Pathology solution — one of the company’s latest innovations in its Expanse EHR.
-
XPANCEO To Develop The First Laboratory Optic Testing System To Accelerate Smart Contact Lens Production Worldwide
2/20/2024
XPANCEO, a deep tech company that is developing the first smart contact lenses with XR and health monitoring features, has announced a successful proof of concept for the world’s first augmented reality holographic lens testing system, marking an essential step towards progressing from Apple Vision Pro to the next generation of computing – XR smart contact lenses.
-
ProPhase Labs Announces Significant Progress In BE-Smart Esophageal Cancer Test Development USPTO Grants Additional Broad Patents For BE-SMART
2/20/2024
ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics and diagnostics company, today announced important developments in the Company’s efforts to commercialize its novel BE-SMART esophageal cancer diagnostic test.
-
Avails Medical Announces FDA Clearance Of Its eQUANT™ System To Accelerate Workflow For Antibiotic Susceptibility Testing
2/20/2024
Avails Medical, Inc., a leader in the development of rapid, automated and fully electrical antibiotic susceptibility testing (AST) technologies, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its groundbreaking eQUANTTM system.
-
Werfen Receives CE Mark For Aptiva® Antiphospholipid Syndrome Reagents
2/19/2024
Werfen today announced it has received CE (Conformité Européenne) mark for its Aptiva® Antiphospholipid Syndrome (APS) Immunoglobulin G (IgG) and Immunoglobulin M (IgM) reagents under the European Union's (EU) In Vitro Diagnostic Medical Devices Regulation (IVDR).